Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition. (2018)
Attributed to:
Characterising and targeting aberrant enhancer function in acute myeloid leukaemia (AML)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood-2017-12-820035
PubMed Identifier: 29463564
Publication URI: http://europepmc.org/abstract/MED/29463564
Type: Journal Article/Review
Volume: 131
Parent Publication: Blood
Issue: 15
ISSN: 0006-4971